

Publisher: Spandidos Publications
E-ISSN: 1791-3004|12|3|3711-3717
ISSN: 1791-2997
Source: Molecular Medicine Reports, Vol.12, Iss.3, 2015-01, pp. : 3711-3717
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The ability to reprogram induced pluripotent stem (iPS) cells from somatic cells may facilitate significant advances in regenerative medicine. MicroRNAs (miRNAs) are involved in a number of core biological processes, including cardiogenesis, hematopoietic lineage differentiation and oncogenesis. An improved understanding of the complex molecular signals that are required for the differentiation of iPS cells into endothelial cells (ECs) may allow specific targeting of their activity in order to enhance cell differentiation and promote tissue regeneration. The present study reports that miR199a is involved in EC differentiation from iPS cells. Augmented expression of miR199a was detected during EC differentiation, and reached higher levels during the later stages of this process. Furthermore, miR199a inhibited the differentiation of iPS cells into smooth muscle cells. Notably, sirtuin 1 was identified as a target of miR199a . Finally, the ability of miR199a to induce angiogenesis was evaluated in vitro, using Matrigel plugs assays. This may indicate a novel function for miR199a as a regulator of the phenotypic switch during vascular cell differentiation. The present study provides support to the notion that with an understanding of the molecular mechanisms underlying vascular cell differentiation, stem cell regenerative therapy may ultimately be developed as an effective treatment for cardiovascular disease.
Related content








Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 5, 2016-03 ,pp. :


Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. :